US5767259A
(en)
|
1994-12-27 |
1998-06-16 |
Naxcor |
Oligonucleotides containing base-free linking groups with photoactivatable side chains
|
US6737236B1
(en)
*
|
1997-01-08 |
2004-05-18 |
Proligo, Llc |
Bioconjugation of macromolecules
|
US20030165888A1
(en)
*
|
2001-07-18 |
2003-09-04 |
Brown Bob D. |
Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
|
US6518017B1
(en)
|
1997-10-02 |
2003-02-11 |
Oasis Biosciences Incorporated |
Combinatorial antisense library
|
US7427678B2
(en)
|
1998-01-08 |
2008-09-23 |
Sigma-Aldrich Co. |
Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
|
AU752220B2
(en)
*
|
1998-01-27 |
2002-09-12 |
British Biocell International Limited |
Modified nucleic acid probes and uses thereof
|
EP1105539A2
(en)
|
1998-08-21 |
2001-06-13 |
Naxcor |
Assays using crosslinkable immobilized nucleic acids
|
US6303799B1
(en)
|
1998-11-10 |
2001-10-16 |
Naxcor |
Polynucleotide crosslinking agents
|
GB9825687D0
(en)
*
|
1998-11-25 |
1999-01-20 |
Link Technologies Ltd |
Oligonucleotide conjugation
|
EP1173614A4
(en)
*
|
1999-04-08 |
2003-10-29 |
Oasis Biosciences Inc |
Antisense oligonucleotides comprising universal and/or degenerate bases
|
PT1471926E
(en)
|
1999-06-01 |
2011-03-11 |
Baylor College Medicine |
Compositions and methods for the therapeutic use of an atonal-associated sequence
|
US6200781B1
(en)
|
1999-06-25 |
2001-03-13 |
Integrated Genetic Devices, Ltd. |
Apparatus, system and method for automated execution and analysis of biological and chemical reactions
|
US6290831B1
(en)
|
1999-08-30 |
2001-09-18 |
Integrated Genetic Devices, Ltd. |
Electrophoretic system for real time detection of multiple electrophoresed biopolymers
|
AU2000261968A1
(en)
*
|
2000-03-06 |
2001-09-17 |
The Johns-Hopkins University |
Scatter controlled emission for optical taggants and chemical sensors
|
US6528318B1
(en)
*
|
2000-03-06 |
2003-03-04 |
The Johns Hopkins University |
Scatter controlled emission for optical taggants and chemical sensors
|
US6573048B1
(en)
*
|
2000-04-18 |
2003-06-03 |
Naxcor |
Degradable nucleic acid probes and nucleic acid detection methods
|
US20040067498A1
(en)
*
|
2000-04-28 |
2004-04-08 |
Ahmed Chenna |
Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
|
WO2002102820A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
US7241566B2
(en)
*
|
2001-06-22 |
2007-07-10 |
Marshfield Clinic |
Methods and oligonucleotides for the detection of Salmonella sp., E. coli O157:H7, and Listeria monocytogenes
|
DE10147074A1
(en)
*
|
2001-09-25 |
2003-05-08 |
Beru Ag |
Method for operating a multi-stage electric heater consisting of several heating elements
|
JP2005511033A
(en)
*
|
2001-11-09 |
2005-04-28 |
アクララ バイオサイエンシーズ, インコーポレイテッド |
Determination of nucleic acid sequences by cleavage and separation of tag-containing constructs
|
DE20200926U1
(en)
*
|
2002-01-23 |
2002-04-18 |
Hegenscheidt Mfd Gmbh & Co Kg |
Deep rolling device of a deep rolling machine for crankshafts
|
US7098326B2
(en)
|
2002-01-23 |
2006-08-29 |
Sigma-Aldrich Co. |
Methods for the integrated synthesis and purification of oligonucleotides
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP2213737B1
(en)
|
2002-02-01 |
2012-11-07 |
Life Technologies Corporation |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
DE60324778D1
(en)
|
2002-03-15 |
2009-01-02 |
Nuevolution As |
AN IMPROVED METHOD FOR SYNTHESIS OF MATTRESS-RELATED MOLECULES
|
WO2003078446A2
(en)
*
|
2002-03-15 |
2003-09-25 |
Nuevolution A/S |
A building block forming a c-c or a c-hetero atom bond upon reaction
|
EP1487849A2
(en)
*
|
2002-03-15 |
2004-12-22 |
Nuevolution A/S |
A building block capable of transferring a functional entity
|
US20050221318A1
(en)
*
|
2002-03-15 |
2005-10-06 |
Gouliaev Alex H |
Building block forming a c-c bond upon reaction
|
US7211382B2
(en)
*
|
2002-04-09 |
2007-05-01 |
Orchid Cellmark Inc. |
Primer extension using modified nucleotides
|
ATE497774T1
(en)
|
2002-07-15 |
2011-02-15 |
Univ Texas |
SCREENING COMBINATORY PROTEIN LIBRARIES USING PERIPLASMATIC EXPRESSION
|
US10730906B2
(en)
|
2002-08-01 |
2020-08-04 |
Nuevolutions A/S |
Multi-step synthesis of templated molecules
|
JP4796299B2
(en)
|
2002-08-12 |
2011-10-19 |
ジェンネレックス インコーポレイティッド |
Methods and compositions for poxviruses and cancer
|
ATE513055T1
(en)
*
|
2002-10-30 |
2011-07-15 |
Nuevolution As |
ENZYMATIC CODING
|
US9121110B2
(en)
*
|
2002-12-19 |
2015-09-01 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
JP4791043B2
(en)
|
2002-12-31 |
2011-10-12 |
プロリゴ・エルエルシー |
Methods and compositions for synthesizing two or more oligonucleotides in tandem on the same solid support
|
EP1597395A2
(en)
*
|
2003-02-21 |
2005-11-23 |
Nuevolution A/S |
Method for producing second-generation library
|
US20060269920A1
(en)
*
|
2003-02-21 |
2006-11-30 |
Nuevolution A/S |
Method for obtaining structural information about an encoded molecule
|
WO2004083427A2
(en)
*
|
2003-03-20 |
2004-09-30 |
Nuevolution A/S |
Ligational encoding of small molecules
|
WO2004092412A2
(en)
|
2003-03-31 |
2004-10-28 |
Roche Diagnostics Gmbh |
Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
|
FR2855269B1
(en)
*
|
2003-05-21 |
2007-06-08 |
Commissariat Energie Atomique |
DEVICE AND METHODS FOR HANGING / REMOVING A TARGET OR OBJECT PRESENT IN A SAMPLE
|
CN1878866B
(en)
|
2003-07-25 |
2012-08-01 |
安比恩股份有限公司 |
Methods and compositions for preparing RNA from a fixed sample
|
US20050059024A1
(en)
|
2003-07-25 |
2005-03-17 |
Ambion, Inc. |
Methods and compositions for isolating small RNA molecules
|
US7087437B2
(en)
*
|
2003-09-16 |
2006-08-08 |
Vici Gig Harbor Group, Inc. |
Direct vial surface sorbent micro extraction device and method
|
EP1670939B1
(en)
|
2003-09-18 |
2009-11-04 |
Nuevolution A/S |
A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
|
EP1730277B1
(en)
*
|
2004-03-22 |
2009-10-28 |
Nuevolution A/S |
Ligational encoding using building block oligonucleotides
|
ES2345993T3
(en)
|
2004-09-14 |
2010-10-07 |
The Regents Of The University Of Colorado, A Body Corporate |
METHOD FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC ADDRESSING.
|
US20060246463A1
(en)
*
|
2005-04-20 |
2006-11-02 |
Vevea Dirk N |
Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
|
US20060240442A1
(en)
*
|
2005-04-20 |
2006-10-26 |
Vevea Dirk N |
Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
|
KR101335218B1
(en)
|
2005-05-02 |
2013-12-12 |
바스프 에스이 |
New labelling strategies for the sensitive detection of analytes
|
ATE479699T1
(en)
|
2005-05-02 |
2010-09-15 |
Baseclick Gmbh |
NEW MARKING STRATEGIES FOR SENSITIVE DETECTION OF ANALYTES
|
KR20090004839A
(en)
|
2005-09-07 |
2009-01-12 |
제네렉스, 인코포레이티드 |
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
EP1937850B1
(en)
|
2005-10-27 |
2019-05-29 |
The President and Fellows of Harvard College |
Methods and compositions for labeling nucleic acids
|
ES2901551T3
(en)
|
2005-12-01 |
2022-03-22 |
Nuevolution As |
Enzymatic Encoding Methods for Efficient Synthesis of Large Libraries
|
WO2008019162A2
(en)
|
2006-01-18 |
2008-02-14 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
US8114636B2
(en)
|
2006-02-10 |
2012-02-14 |
Life Technologies Corporation |
Labeling and detection of nucleic acids
|
US8716033B2
(en)
|
2006-02-10 |
2014-05-06 |
Life Technologies Corporation |
Oligosaccharide modification and labeling of proteins
|
CA2921048C
(en)
|
2006-09-15 |
2018-06-05 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
CA2667136A1
(en)
|
2006-10-31 |
2008-05-08 |
Baseclick Gmbh |
Click chemistry for the production of reporter molecules
|
EP2102239B1
(en)
|
2006-11-30 |
2012-04-25 |
Research Development Foundation |
Improved immunoglobulin libraries
|
CA2687292C
(en)
*
|
2007-04-10 |
2017-07-04 |
Nanostring Technologies, Inc. |
Methods and computer systems for identifying target-specific sequences for use in nanoreporters
|
CA2685675C
(en)
|
2007-05-01 |
2016-02-16 |
Research Development Foundation |
Immunoglobulin fc libraries
|
KR20100089060A
(en)
*
|
2007-10-04 |
2010-08-11 |
할싸이언 몰레큘러 |
Sequencing nucleic acid polymers with electron microscopy
|
US8133515B2
(en)
|
2007-11-21 |
2012-03-13 |
University Of Georgia Research Foundation, Inc. |
Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
|
CN104263816B
(en)
|
2008-05-16 |
2018-10-19 |
生命技术公司 |
Double label method for measuring cell Proliferation
|
BRPI0920041A2
(en)
|
2008-10-06 |
2017-06-27 |
Univ Chicago |
bacterial eap, emp and / or adsa protein compositions and processes
|
PL3281947T3
(en)
|
2009-04-03 |
2020-07-27 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
EP2789689B1
(en)
|
2009-06-29 |
2016-04-27 |
Luminex Corporation |
Chimeric primers with hairpin conformations and methods of using same
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
US9512481B2
(en)
|
2009-09-11 |
2016-12-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Polymorphisms in the PDE3A gene
|
KR101759888B1
(en)
|
2009-09-14 |
2017-07-20 |
신라젠(주) |
Oncolytic vaccinia virus combination cancer therapy
|
EP2510088B1
(en)
|
2009-12-10 |
2016-10-05 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
WO2011079273A2
(en)
|
2009-12-23 |
2011-06-30 |
Arca Biopharma, Inc. |
Methods and compositions for cardiovascular diseases and conditions
|
JP2013523818A
(en)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
Compositions and methods relating to protein A (SpA) antibodies as enhancers of immune responses
|
WO2011127933A1
(en)
|
2010-04-16 |
2011-10-20 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
JP6002128B2
(en)
|
2010-07-02 |
2016-10-05 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
Compositions and methods related to protein A (SpA) variants
|
WO2012034067A1
(en)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
US9919047B2
(en)
|
2011-01-04 |
2018-03-20 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
EP2673299B1
(en)
|
2011-02-07 |
2017-05-10 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
WO2012158238A2
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
|
CA2829300A1
(en)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
EP2694534B1
(en)
|
2011-04-08 |
2018-06-20 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
EP2718427B1
(en)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Compositions for glioblastoma treatment
|
US10040853B2
(en)
|
2011-09-09 |
2018-08-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving NKG2D inhibitors and cancer
|
WO2013053899A1
(en)
|
2011-10-12 |
2013-04-18 |
Moeller Niels Iversen |
Peptides derived from campylobacter jejuni and their use in vaccination
|
WO2013096798A2
(en)
|
2011-12-22 |
2013-06-27 |
Ibis Biosciences, Inc. |
Amplification of a sequence from a ribonucleic acid
|
CA2861387A1
(en)
|
2012-02-02 |
2013-08-08 |
Invenra, Inc. |
High throughput screen for biologically active polypeptides
|
DK2844275T3
(en)
|
2012-04-26 |
2020-07-13 |
Univ Chicago |
Staphylococcal coagulase antigens and methods of using them
|
AU2013315800A1
(en)
|
2012-09-11 |
2015-03-12 |
Theranos Ip Company, Llc |
Information management systems and methods using a biological signature
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
CA2901501C
(en)
|
2013-02-21 |
2023-03-07 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Vaccine composition
|
EP3052193B1
(en)
|
2013-10-03 |
2018-01-31 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
WO2015082536A1
(en)
|
2013-12-03 |
2015-06-11 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
WO2016075305A2
(en)
|
2014-11-13 |
2016-05-19 |
Evaxion Biotech Aps |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
WO2016086227A2
(en)
|
2014-11-26 |
2016-06-02 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
EP4279080A3
(en)
|
2015-01-12 |
2024-02-21 |
Evaxion Biotech A/S |
Treatment and prophylaxis of k. pneumoniae infection
|
AU2016219511B2
(en)
|
2015-02-09 |
2020-11-12 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
EP3070178B1
(en)
|
2015-03-20 |
2020-02-12 |
Albert-Ludwigs-Universität Freiburg |
Method for diagnosing breast cancer
|
EP4116316A1
(en)
|
2015-07-04 |
2023-01-11 |
Evaxion Biotech A/S |
Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
|
WO2017040380A2
(en)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Engineered antibody fc variants
|
WO2017144523A1
(en)
|
2016-02-22 |
2017-08-31 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
WO2018127545A1
(en)
|
2017-01-05 |
2018-07-12 |
Evaxion Biotech Aps |
Vaccines targeting pseudomonas aeruginosa
|
CN110462062A
(en)
|
2017-01-26 |
2019-11-15 |
俄克拉荷马医学研究基金会 |
Systemic loupus erythematosus Disease Activity, intensity and the biomarker of acute attack
|
KR102554477B1
(en)
|
2018-10-18 |
2023-07-11 |
오클라호마 메디컬 리써치 화운데이션 |
Biomarkers for Systemic Lupus Erythematosus (SLE) Disease Activity Immunity Index to Characterize Disease Activity
|
WO2020083904A1
(en)
|
2018-10-22 |
2020-04-30 |
Evaxion Biotech Aps |
Vaccines targeting m. catharrhalis
|
US20220143168A1
(en)
|
2019-02-27 |
2022-05-12 |
Evaxion Biotech A/S |
Vaccines targeting H. influenzae
|
EP3772543B1
(en)
|
2019-08-09 |
2023-09-27 |
Albert-Ludwigs-Universität Freiburg |
Method for diagnosing breast cancer
|
WO2021140123A1
(en)
|
2020-01-06 |
2021-07-15 |
Evaxion Biotech Aps |
Vaccines targeting neisseria gonorrhoeae
|
US20240010742A1
(en)
|
2022-06-10 |
2024-01-11 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|